DK0579618T3 - Pyridin- og imidazolafledte midler til cardiovaskulære sygdomme - Google Patents
Pyridin- og imidazolafledte midler til cardiovaskulære sygdommeInfo
- Publication number
- DK0579618T3 DK0579618T3 DK92906439T DK92906439T DK0579618T3 DK 0579618 T3 DK0579618 T3 DK 0579618T3 DK 92906439 T DK92906439 T DK 92906439T DK 92906439 T DK92906439 T DK 92906439T DK 0579618 T3 DK0579618 T3 DK 0579618T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- pct
- thromboxane
- optionally
- chch3
- Prior art date
Links
- SBPIDKODQVLBGV-UHFFFAOYSA-N 1h-imidazole;pyridine Chemical compound C1=CNC=N1.C1=CC=NC=C1 SBPIDKODQVLBGV-UHFFFAOYSA-N 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 2
- -1 1-imidazolyl Chemical group 0.000 abstract 2
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical group C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 abstract 2
- 101100167062 Caenorhabditis elegans chch-3 gene Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 abstract 1
- 108010069102 Thromboxane-A synthase Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Treating Waste Gases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919107043A GB9107043D0 (en) | 1991-04-04 | 1991-04-04 | Therapeutic agents |
| PCT/EP1992/000591 WO1992017451A1 (en) | 1991-04-04 | 1992-03-17 | Pyridine- and imidazole-derived agents for cardiovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0579618T3 true DK0579618T3 (da) | 2000-01-03 |
Family
ID=10692617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92906439T DK0579618T3 (da) | 1991-04-04 | 1992-03-17 | Pyridin- og imidazolafledte midler til cardiovaskulære sygdomme |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5457118A (da) |
| EP (1) | EP0579618B1 (da) |
| JP (1) | JP3088015B2 (da) |
| AT (1) | ATE185560T1 (da) |
| CA (1) | CA2104456C (da) |
| DE (1) | DE69230141T2 (da) |
| DK (1) | DK0579618T3 (da) |
| ES (1) | ES2138594T3 (da) |
| FI (2) | FI104070B1 (da) |
| GB (1) | GB9107043D0 (da) |
| GR (1) | GR3032308T3 (da) |
| IE (1) | IE921060A1 (da) |
| PT (1) | PT100332B (da) |
| WO (1) | WO1992017451A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9220137D0 (en) * | 1992-09-23 | 1992-11-04 | Pfizer Ltd | Therapeutic agents |
| AU2044297A (en) * | 1996-03-29 | 1997-10-22 | Meiji Seika Kaisha Ltd. | Novel heterocyclic compounds having platelet aggregation inhibitory effects |
| EP1080075B1 (en) * | 1998-03-23 | 2004-08-11 | Aventis Pharmaceuticals Inc. | Piperididinyl and n-amidinopiperidinyl derivatives |
| JP4202250B2 (ja) | 2001-07-25 | 2008-12-24 | バイオマリン ファーマシューティカル インコーポレイテッド | 血液脳関門輸送を調節するための組成物および方法 |
| US6722688B2 (en) | 2001-11-21 | 2004-04-20 | The Burton Corporation | Snowboard binding system |
| JP2006514084A (ja) * | 2002-12-03 | 2006-04-27 | ヴェラ ファーマスーティカルズ インコーポレイテッド | １−（３−ヒドロキシ−４−メトキシフェニル）−４−メチル−５−エチル−７，８−ジメトキシ−５ｈ−２，３−ベンゾジアゼピンの製薬組成物及びその用途 |
| AU2003293405A1 (en) * | 2002-12-03 | 2004-06-23 | Vela Pharmaceuticals, Inc. | Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof |
| US20070032479A1 (en) * | 2003-12-03 | 2007-02-08 | Leventer Steven M | Treatment of inflammatory disorders of the epithelium with low dose 2,3-benzodiazepines |
| EP3827747A1 (en) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
| US20080064729A1 (en) * | 2006-09-07 | 2008-03-13 | Millennium Pharmaceuticals, Inc. | Phenethylamide derivatives with kinase inhibitory activity |
| CN101594878A (zh) | 2006-09-18 | 2009-12-02 | 雷普特药品公司 | 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗 |
| DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
| CN110075069A (zh) | 2009-05-06 | 2019-08-02 | 实验室护肤股份有限公司 | 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60172964A (ja) * | 1984-02-15 | 1985-09-06 | Tanabe Seiyaku Co Ltd | 桂皮酸誘導体及びその製法 |
| US4837333A (en) * | 1987-05-14 | 1989-06-06 | G. D. Searle & Co. | Substituted alkylidene imidazoles |
| DE3932403A1 (de) * | 1989-05-12 | 1991-04-11 | Thomae Gmbh Dr K | Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| IL94805A (en) * | 1989-06-28 | 1994-04-12 | Ciba Geigy Ag | (Arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids, processfor their preparation and pharmaceutical compositions containing them |
-
1991
- 1991-04-04 GB GB919107043A patent/GB9107043D0/en active Pending
-
1992
- 1992-03-17 DK DK92906439T patent/DK0579618T3/da active
- 1992-03-17 WO PCT/EP1992/000591 patent/WO1992017451A1/en not_active Ceased
- 1992-03-17 ES ES92906439T patent/ES2138594T3/es not_active Expired - Lifetime
- 1992-03-17 EP EP92906439A patent/EP0579618B1/en not_active Expired - Lifetime
- 1992-03-17 US US08/133,155 patent/US5457118A/en not_active Expired - Fee Related
- 1992-03-17 AT AT92906439T patent/ATE185560T1/de not_active IP Right Cessation
- 1992-03-17 DE DE69230141T patent/DE69230141T2/de not_active Expired - Fee Related
- 1992-03-17 JP JP04505819A patent/JP3088015B2/ja not_active Expired - Fee Related
- 1992-03-17 CA CA002104456A patent/CA2104456C/en not_active Expired - Fee Related
- 1992-04-02 PT PT100332A patent/PT100332B/pt not_active IP Right Cessation
- 1992-04-03 IE IE106092A patent/IE921060A1/en not_active IP Right Cessation
-
1993
- 1993-09-15 FI FI934045A patent/FI104070B1/fi not_active IP Right Cessation
-
1995
- 1995-07-14 US US08/502,748 patent/US5705523A/en not_active Expired - Fee Related
-
1999
- 1999-02-01 FI FI990179A patent/FI990179A0/fi unknown
-
2000
- 2000-01-04 GR GR20000400008T patent/GR3032308T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT100332B (pt) | 1999-06-30 |
| FI104070B (fi) | 1999-11-15 |
| EP0579618A1 (en) | 1994-01-26 |
| DE69230141T2 (de) | 2000-02-03 |
| FI990179A7 (fi) | 1999-02-01 |
| FI104070B1 (fi) | 1999-11-15 |
| CA2104456A1 (en) | 1992-10-05 |
| US5705523A (en) | 1998-01-06 |
| US5457118A (en) | 1995-10-10 |
| FI934045A0 (fi) | 1993-09-15 |
| EP0579618B1 (en) | 1999-10-13 |
| ES2138594T3 (es) | 2000-01-16 |
| IE921060A1 (en) | 1992-10-07 |
| FI990179A0 (fi) | 1999-02-01 |
| JPH06506200A (ja) | 1994-07-14 |
| DE69230141D1 (de) | 1999-11-18 |
| JP3088015B2 (ja) | 2000-09-18 |
| CA2104456C (en) | 1996-12-10 |
| WO1992017451A1 (en) | 1992-10-15 |
| GR3032308T3 (en) | 2000-04-27 |
| PT100332A (pt) | 1993-07-30 |
| ATE185560T1 (de) | 1999-10-15 |
| GB9107043D0 (en) | 1991-05-22 |
| FI934045A7 (fi) | 1993-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0579618T3 (da) | Pyridin- og imidazolafledte midler til cardiovaskulære sygdomme | |
| GB9317764D0 (en) | Therapeutic compound | |
| TW200738706A (en) | Pyrido-, pyrazo-and pyrimido-pyrimidine derivatives and their use as mTOR inhibitors | |
| AR083339A1 (es) | Compuestos de quinazolina como bloqueadores de los canales de sodio | |
| LV10246A (lv) | Jauni aizvietotie salicilskabes atvasinajumi | |
| TW200510353A (en) | Alpha substituted carboxylic acids as PPAR modulators | |
| WO2002038553A3 (en) | Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists | |
| DE69522945D1 (de) | Verbindungen, die als antiproliferative mittel und als garft inhibitoren verwendbar sind | |
| ATE288895T1 (de) | Wachstumshormon-freisetzende oxindolderivate | |
| NO20021294L (no) | Benzopyranderivat | |
| AP1816A (en) | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists. | |
| SE9703377D0 (sv) | New compounds | |
| BG94282A (bg) | 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они | |
| SE0101579D0 (sv) | New compounds | |
| AR039111A1 (es) | Tiopirimidinas e isotiazolpirimidinas inhibidoras de quinasas | |
| DK0510003T3 (da) | Piperidin-og pyrrolidinderivater | |
| NZ513594A (en) | Heterocyclic compounds, intermediates thereof and elastase inhibitors | |
| AR045006A1 (es) | Derivados de quinazolinona 5-sustituidos | |
| IL182547A0 (en) | 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury | |
| AR027035A1 (es) | Pirroles sustituidos | |
| SE9904177D0 (sv) | Novel compounds | |
| CO4940439A1 (es) | COMPUESTOS 4-AMINO-6,7-DISUSTITUIDOS-PIRIDO-[2,3-d] PIRIMI- DINA | |
| PE20010167A1 (es) | Amidas de acidos fenilciclohexanocarboxilicos sustituidos con actividad inhibidora de la incorporacion de adenosina | |
| TW200621227A (en) | Medicament for preventing or treating fatty liver | |
| HRP20090617T1 (hr) | Protutumorska kombinacija koja sadrži substituirane akriloil distamicinske derivate i protutijela koja inhibiraju čimbenike rasta ili njihove receptore |